Jafari A

No ORCID on file · 5 papers in corpus
2026
JBMR plus ·doi:10.1093/jbmrpl/ziag093

Teriparatide, (recombinant human PTH 1-34) is an Food and Drug Administration (FDA)-approved anabolic therapy for osteoporosis. In patients with severe bone loss, daily teriparatide injections increase osteoblastic activity and bone turnove…

2025
Journal of medical case reports ·doi:10.1186/s13256-025-05441-6

BackgroundClear cell carcinoma of the colon is a rare entity in colon malignancy. All of the cases involving primary colon clear cell carcinoma are case studies. Since clear cell component can be seen in colon metastasis, adenocarcinoma, an…

2024
Nutrition reviews ·doi:10.1093/nutrit/nuad054

ContextNonalcoholic fatty liver disease (NAFLD) is prevalent in 25-30% of British and European populations, representing a potential global public health crisis. Marine omega-3 (n-3) polyunsaturated fatty acids offer well-evidenced benefits…

2023
International journal of surgery case reports ·doi:10.1016/j.ijscr.2023.108296

IntroductionEndometrial stromal sarcoma (ESS) is a rare malignancy of uterine in middle aged women. There are numerous subtypes for ESS which share the same clinical picture of uterine bleeding and pelvic pain. Consequently, diagnosis and t…

2022
International journal of molecular sciences ·doi:10.3390/ijms232415983

The cysteine protease legumain (also known as asparaginyl endopeptidase or δ-secretase) is the only known mammalian asparaginyl endopeptidase and is primarily localized to the endolysosomal system, although it is also found extracellularly …